Showing posts with label Current Drug Metabolism. Show all posts
Liver is an organ that performs multiple functions in a
human body. Manufacturing blood protein to facilitate clotting, storage of glucose
in the form of glycogen, detoxification of blood, breaking saturated fats into
cholesterol etc., are all the functions that fall in this profile.
In early stages, liver cirrhosis begins by the development of scar tissues that may be due to obesity or alcohol abuse or chronic liver diseaselike hepatitis A, B and C. Scarred tissues become an obstruction in the blood flow to liver. The obstruction of scars allows a very slow passage of blood that delays the functions of liver and alters its efficacy as per body’s requirement.
In early stages, liver cirrhosis begins by the development of scar tissues that may be due to obesity or alcohol abuse or chronic liver diseaselike hepatitis A, B and C. Scarred tissues become an obstruction in the blood flow to liver. The obstruction of scars allows a very slow passage of blood that delays the functions of liver and alters its efficacy as per body’s requirement.
Along with other liver functions cirrhosis affects drug metabolism
extensively. Since the healthy liver tissues are destroyed in cirrhosis,
cytochrome p450 (enzyme that catalyzes metabolism of organic substances) and
other enzymes responsible for drug metabolism are also altered, thus the
enzymatic activity becomes variant.This online article“The Effect of Liver Cirrhosis on the Regulation and Expression of drug metabolism enzymes”has many
interesting facts about drug metabolizing enzymes such as CYP1A, CYP3A, CYP2A
etc.
There is not one confirmed source for cessation of liver
into cirrhosis gradually. Besides the ones mentioned above, infectious diseases
are said to have a direct proportionality with cirrhosis. Liver scaring alters
production of cytokines and vascular responses. The article “The Molecular
Basis of Susceptibility to Infection in Liver Cirrhosis”also notified that
cellular immunity suffers an intense disruption due to
the progression in liver diseases with essential details.
The above research articles were published by Bentham
Science Publishers. They are a research publication company
who offer many details on liver and associated studies. They have a variety of articles
published that share maximum details with sheer authenticity on the minimized
liver function due to cirrhosis and associated complications.It publishes 130 online and print journals,
150 + open access journals, and related print/online book series. Also, they feature reviews in-depth of the original
articles along with relevant pre-clinical trials to facilitate broad learning.
For a complete list, click on Bentham Science Publishers’ Journals Impacting Science
Top Reads: ‘Sirtuins as Possible Drug Targets in Type 2 Diabetes
Tuesday, 22 July 2014
Posted by Unknown
The climbing rate of type 2 diabetes mellitus (T2dm) is a
significant health issue in the industrialized nations, and new helpful
techniques to counteract T2dm are earnestly required around the world. It is
well realized that calorie confinement (CR) can hinder the maturing process in
living beings going from yeast to rodents and deferral the onset of various
age-related sicknesses, including diabetes. Atoms that mimic CR metabolically
might subsequently look for new therapeutic targets for T2dm.
Sirtuin1 (Sirt1), the mammalian homolog of Sir2, was
initially distinguished as a Nad+-subordinate histone deacetylase, and its
action is nearly connected with life span under CR. Developing confirmation
proposes that Sirt1 directs glucose-lipid digestion system through its
deacetylase movement for some known substrates and has numerous parts in the metabolic
pathway through its run or roundabout association in insulin motioning in
insulin-touchy organs, including fat tissue, liver and skeletal muscle.
Furthermore, Sirt1 manages insulin emission, and adiponectin
creation, aggravation, gluconeogenesis, circadian rhythms and oxidative
anxiety, which together help the advancement of insulin safety. In addition,
the overexpression of Sirt1 and a few Sirt1 activators have valuable
consequences for glucose homeostasis and insulin affectability in diabetic creature
models and people.
Similarly, Sirt1 may represent a new therapeutic focus for the anticipation of illnesses identified with insulin safety and T2dm. Moreover, Sirt3 and Sirt6 assume significant parts in glucose and lipid digestion system. This review, the current metabolism of drugs understanding of the biotic capacities of Sirt1, Sirt3 and Sirt6 in digestion system,and their potential part as helpful focuses in T2dm, is summarized.
Similarly, Sirt1 may represent a new therapeutic focus for the anticipation of illnesses identified with insulin safety and T2dm. Moreover, Sirt3 and Sirt6 assume significant parts in glucose and lipid digestion system. This review, the current metabolism of drugs understanding of the biotic capacities of Sirt1, Sirt3 and Sirt6 in digestion system,and their potential part as helpful focuses in T2dm, is summarized.
For a complete list, click on Bentham Science Publishers’ Journals Impacting Science
Top 2 High Impact Factor Journals of Bentham Science Publishers
Saturday, 14 June 2014
Posted by Unknown
Academic
literature, research and science receive great services from scholarly
publishing. The industry is majorly dominated by subscription-based publishing
which has existed for as long as the scholarly journals publishing it (Paul
Peters, 2007). Academic journals and the quality of the research published in
these journals are judged by their impact factor; a measure of the number of
citation to articles published in the journals.
Bentham
Science is a fast growing scholarly journals publishers and has been serving
the libraries and academia for the past 3 decades. They have approximately
published 122 subscription based journals, while their flagship products
include 32 High Impact Factor Journals.
1.
Current Genre
therapy is a bi-monthly peer-reviewed
journal, with an impact factor as high as 5.
This journal aims to target academic and industrial researchers and
scientists interested in major topics concerning basic and clinical application
of gene and cell therapy. It publishes original and latest developments in gene
transfers and gene expression analysis, as well as human clinical applications
amongst other topics.
2.
Current Drug Metabolism has an impact factor of 4.04. It aims to cover all
the outstanding research developments in drug metabolism. The journal,
moreover, acts as an international forum for the publication of timely reviews
and guest edited issues in drug metabolism.